Free Trial
ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Australian Pharmaceutical Industries logo

About Australian Pharmaceutical Industries Stock (ASX:API)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
453,647 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

API Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Elon Musk's xAI launched its own API
See More Headlines

API Stock Analysis - Frequently Asked Questions

Australian Pharmaceutical Industries Limited (ASX:API) released its earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU).

Company Calendar

Last Earnings
4/17/2019
Today
6/06/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Medical Equipment Wholesale
Sub-Industry
Computer Software
Current Symbol
ASX:API
CIK
N/A
Fax
N/A
Employees
1,310
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.28
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.00 billion
Price / Cash Flow
8.26
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:API) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners